ATE546548T1 - Verfahren zur prognose des nutzens einer antioxidationshemmenden therapie zur vorbeugung von herz-kreislauf-erkrankungen bei hyperglykämischen patienten - Google Patents
Verfahren zur prognose des nutzens einer antioxidationshemmenden therapie zur vorbeugung von herz-kreislauf-erkrankungen bei hyperglykämischen patientenInfo
- Publication number
- ATE546548T1 ATE546548T1 AT03780603T AT03780603T ATE546548T1 AT E546548 T1 ATE546548 T1 AT E546548T1 AT 03780603 T AT03780603 T AT 03780603T AT 03780603 T AT03780603 T AT 03780603T AT E546548 T1 ATE546548 T1 AT E546548T1
- Authority
- AT
- Austria
- Prior art keywords
- benefit
- predicting
- cardiovascular disease
- preventing cardiovascular
- hyperglycemic patients
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43743903P | 2003-01-02 | 2003-01-02 | |
| PCT/IL2003/001120 WO2004060135A2 (en) | 2003-01-02 | 2003-12-31 | Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE546548T1 true ATE546548T1 (de) | 2012-03-15 |
Family
ID=32713185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03780603T ATE546548T1 (de) | 2003-01-02 | 2003-12-31 | Verfahren zur prognose des nutzens einer antioxidationshemmenden therapie zur vorbeugung von herz-kreislauf-erkrankungen bei hyperglykämischen patienten |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1587953B1 (de) |
| JP (1) | JP2006512079A (de) |
| CN (1) | CN1780921B (de) |
| AT (1) | ATE546548T1 (de) |
| AU (1) | AU2003288700B2 (de) |
| CA (1) | CA2512499A1 (de) |
| WO (1) | WO2004060135A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608393B2 (en) | 2000-04-20 | 2009-10-27 | Rappaport Family Institute For Research In The Medical Sciences | Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients |
| EP2158333A4 (de) * | 2007-05-14 | 2010-12-29 | Synvista Therapeutics Inc | Verwendung von haptoglobingenotypisierung zur diagnose und behandlung bei fehlerhaftem reversem cholesterintransport |
| WO2022129004A1 (en) | 2020-12-15 | 2022-06-23 | Dsm Ip Assets B.V. | Coated statin tablet comprising vitamin e acetate powder |
| WO2022129002A1 (en) | 2020-12-15 | 2022-06-23 | Dsm Ip Assets B.V. | Coarse dispersion comprising statin and vitamin e oil |
| WO2022129003A1 (en) | 2020-12-15 | 2022-06-23 | Dsm Ip Assets B.V. | Multiparticulate solid oral dosage form comprising statin and vitamin e |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| BE1010935A7 (nl) * | 1997-02-19 | 1999-03-02 | Delanghe Joris Richard Siegfri | Fenotypering van humaan haptoglobine in serum of plasma door middel van quantitatieve agglutinatie met streptococcus antigenen. |
| US6574679B1 (en) | 1999-07-26 | 2003-06-03 | International Business Machines Corporation | Method and apparatus for identifying hardware |
| TWI237116B (en) * | 1999-08-10 | 2005-08-01 | Animal Technology Inst Taiwan | Methods and systems for diagnosing kawasaki disease |
| US6599702B1 (en) * | 2000-04-20 | 2003-07-29 | Rappaport Family Institute For Research In The Medical Sciences | Method of evaluating a risk of a subject of developing vascular complications |
| US6613519B1 (en) | 2000-04-20 | 2003-09-02 | Rappaport Family Institute For Reseach In The Medical Sciences | Method of determining a risk of hyperglycemic patients of developing a cardiovascular disease |
| US6251608B1 (en) * | 2000-04-20 | 2001-06-26 | Technion Research & Development Foundation, Ltd. | Method of determining a potential of a hyperglycemic patients of developing vascular complications |
-
2003
- 2003-12-31 EP EP03780603A patent/EP1587953B1/de not_active Expired - Lifetime
- 2003-12-31 AT AT03780603T patent/ATE546548T1/de active
- 2003-12-31 CA CA002512499A patent/CA2512499A1/en not_active Abandoned
- 2003-12-31 WO PCT/IL2003/001120 patent/WO2004060135A2/en active Application Filing
- 2003-12-31 AU AU2003288700A patent/AU2003288700B2/en not_active Ceased
- 2003-12-31 CN CN200380110094.8A patent/CN1780921B/zh not_active Expired - Fee Related
- 2003-12-31 JP JP2004564404A patent/JP2006512079A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2512499A1 (en) | 2004-07-22 |
| CN1780921B (zh) | 2010-12-08 |
| AU2003288700A1 (en) | 2004-07-29 |
| AU2003288700B2 (en) | 2009-11-19 |
| WO2004060135A3 (en) | 2004-09-10 |
| WO2004060135A2 (en) | 2004-07-22 |
| CN1780921A (zh) | 2006-05-31 |
| EP1587953B1 (de) | 2012-02-22 |
| EP1587953A4 (de) | 2006-03-29 |
| JP2006512079A (ja) | 2006-04-13 |
| EP1587953A2 (de) | 2005-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE355852T1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
| NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
| BRPI0307673A2 (pt) | métodos de tratar doença vascular. | |
| DE60042611D1 (de) | Verfahren zur behandlung von gefässerkrankungen, dxid auszeichnen | |
| DE602004012816D1 (de) | Selbstexpandierbarer Stent und Stenteinbringungssystem zur Behandlung von Gefässerkrankungen | |
| HUP0303917A2 (hu) | Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére | |
| ATE446102T1 (de) | Behandlung von gewichtsverlust bei patienten mit entzündlichen darmerkrankungen mittels s. boulardii | |
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| WO2008027912A3 (en) | Prediction of an agent's or agents' activity across different cells and tissue types | |
| ATE417102T1 (de) | Antisense-oligonukleotide (odn) gegen smad7 und ihre verwendung in der medizin | |
| ATE422357T1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
| WO2000018954A3 (en) | Use of pex in the treatment of metabolic bone diseases | |
| DE60234619D1 (de) | Gene und proteine für verhinderung, vorhersage, prognose und therapie der herzgefäss-krankheit | |
| CY1116938T1 (el) | Αναπληρωτικη θεραπεια της ασθενειας huntington και αλλων ασθενειων πολυγλουταμiνης | |
| WO2004031129A3 (en) | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection | |
| ATE411803T1 (de) | Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür | |
| DK1397681T3 (da) | Fremgangsmåde til identificering af midler til behandling af diabetes | |
| WO2005062706A3 (en) | Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients | |
| WO2009027703A3 (en) | Identifying organ damage | |
| ATE546548T1 (de) | Verfahren zur prognose des nutzens einer antioxidationshemmenden therapie zur vorbeugung von herz-kreislauf-erkrankungen bei hyperglykämischen patienten | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| HUP0203486A2 (hu) | Véralvadással összefüggő betegségek megelőzése és kezelése | |
| DK1596879T3 (da) | Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis | |
| BRPI0512709A (pt) | métodos para prognóstico da resposta terapêutica a agentes atuando no receptor do hormÈnio do crescimento | |
| WO2006007710A3 (en) | Acute inflammatory condition treatment |